Bicara Therapeutics Inc. - 8-K Filing

Bicara Therapeutics appoints Jeremy Bender, Ph.D., and Christy Oliger to its Board; Kiran Mazumdar-Shaw resigns from board roles (Items: 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Offi, 7.01 Regulation FD Disclosure)

SEC EDGAR ·

Tickers: $BCAX

Read the full article at SEC EDGAR

More Regulatory news